Company Monitoring Page for MannKind

job ratings for MannKind

02/06/18
industry:
Biotech
job title:
Sales
company:
MannKind
job rating:
7
Mannkind is not perfect, but no company is. I have a feeling that people actually care about the mission of the company. Still room for improvement like with anything but I have no need to look anywhere else, best company I’ve worked for by far!

latest headlines for company on cafepharma

Why Shares of MannKind Were Up Wednesday
Motley Fool
Thu, 05/11/23 - 09:56 am
Tags:
MannKind, earnings, United Therapeutics
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Tags:
Kyowa Kirin, Takeda, Eiger BioPharmaceuticals, AstraZeneca, Teva Pharmaceutical, Bavarian Nordic, Halozyme, Novartis, MannKind, drug development
After buying in candidate, Mannkind wraps up phase 1 trial of inhaled lung infection prospect
Fierce Pharma
Tue, 09/6/22 - 12:04 pm
Tags:
MannKind, clofazimine, FDA, bacterial lung infections, clinical trials
MannKind Acquires Wearable Insulin Device from Zealand Pharma
Medical Devices and Diagnostics Industry
Tue, 05/17/22 - 10:27 pm
Tags:
MannKind, Zealand Pharma, V-Go, insulin, diabetes, devices, Medtech
FDA declines to approve United-MannKind's lung disease therapy
Yahoo/Reuters
Mon, 10/18/21 - 10:42 pm
Tags:
MannKind, United Therapeutics, Tyvaso, FDA, PAH
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
BioSpace
Wed, 06/16/21 - 11:17 pm
Tags:
MannKind, United Therapeutics, PAH, PH-ILD, FDA, priority review, Tyvaso
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
Tags:
drug development, MannKind, Thirona Bio, pulmonary fibrosis, Oyster Point Pharma, Adaptive Phage Therapeutics, ophthalmic, Takeda, Codexis, ALX Oncology, Eli Lilly, clinical trials, BeiGene, Shoreline Biosciences, oncology
Why MannKind Stock Crushed it Monday
Motley Fool
Mon, 06/15/20 - 11:03 pm
Tags:
MannKind, ADA, diabetes, insulin, Afrezza, inhaled insulin
Why MannKind Is Up Big Today
Motley Fool
Tue, 05/14/19 - 05:00 pm
Tags:
MannKind, inhaled insulin, Afrezza
MannKind (MNKD) Q4 Revenues Rise 254%; Achieves First Ever Qtr Afrezza Gross Profit
Street Insider
Tue, 02/26/19 - 06:34 pm
Tags:
MannKind, earnings, Afrezza
FDA’s OPDP Warns MannKind for Facebook Post
RAPS.org
Tue, 10/16/18 - 11:52 pm
Tags:
Afrezza, warning letter, FDA, OPDP, Facebook, social media, diabetes, MannKind
Struggling MannKind sees shares rocket up on $105M-plus alliance with United on inhaled treprostinil
Endpoints
Tue, 09/4/18 - 09:43 am
Tags:
MannKind, United Therapeutics, PAH, Treprostinil
Can MannKind Corporation Avert Bankruptcy?
Motley Fool
Fri, 08/3/18 - 10:55 pm
Tags:
MannKind, earnings, Afrezza
MannKind (MNKD) Completes Phase 1 Trial of Treprostinil Technosphere for PAH Advancing Development to Next Phase
Street Insider
Fri, 06/8/18 - 11:00 am
Tags:
MannKind, TreT, FDA, PAH
MannKind Q1 Results: The Good, the Bad, and the Ugly
Motley Fool
Thu, 05/10/18 - 09:16 am
Tags:
MannKind, earnings
Why MannKind Corporation Stock Broke Down in April
Motley Fool
Tue, 05/8/18 - 09:54 am
Tags:
MannKind
3 Bright Spots in MannKind Corporation's Q4 Update
Motley Fool
Wed, 02/28/18 - 06:47 pm
Tags:
MannKind, earnings
Why MannKind Corporation Stock Is Falling Back to Earth Today
Motley Fool
Fri, 01/26/18 - 05:23 pm
Tags:
MannKind, diabetes, Afrezza
3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street
Motley Fool
Sun, 01/21/18 - 10:47 am
Tags:
diabetes, Senseonics, Lexicon Pharmaceuticals, MannKind
Why MannKind Corporation Jumped Higher Today
Motley Fool
Tue, 01/2/18 - 07:25 pm
Tags:
MannKind, diabetes, Afrezza

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.